Boosters For All Adults In U.S. Closer With Panel Meeting Set
The Food and Drug Administration is expected to sign off on Pfizer's application before the advisory panel meets Friday.
An influential U.S. advisory panel will discuss expanding eligibility for COVID-19 vaccine booster shots to all adults Friday, a move that could make the shots available nationwide as early as this weekend.
Some cities and states already allow all adults to get boosters of Pfizer's vaccine, but it is not yet official U.S. policy. In the last week, California, New Mexico, Arkansas, West Virginia and Colorado expanded the shots to all adults. New York City made a similar move.
Pfizer asked U.S. regulators last week to allow boosters of its COVID-19 vaccine for anyone 18 or older. The Food and Drug Administration is expected to sign off on Pfizer's application before the advisory panel meets Friday. The final step — CDC's official recommendation — could come soon after the meeting.
The move would greatly expand who is eligible. Boosters are now recommended for people who initially received their second Pfizer or Moderna shots at least six months ago if they're 65 or older or are at high risk of COVID-19 because of health problems or their job or living conditions. Boosters are also recommended for people who received the single-dose Johnson & Johnson vaccine at least two months ago.
Nearly 31 million Americans have already received a dose beyond their original vaccination, including those with weakened immune systems, such as cancer patients and organ transplant recipients who need an extra dose to be fully vaccinated.
While all three vaccines used in the U.S. continue to offer strong protection against severe COVID-19 illness and death, the shots' effectiveness against milder infection can wane over time.
Pfizer has submitted early results of a booster study in 10,000 people to make its case that it's time to further expand the booster campaign. The study found that a booster could restore protection against symptomatic infection to about 95%, even as the extra-contagious delta variant was surging. Side effects were similar to those seen with the company's first two shots.
Members of the panel, the Advisory Committee on Immunization Practices, have debated in prior meetings whether there is sufficient evidence that boosters are currently needed for all adults.
Additional reporting by The Associated Press.
President Biden to end COVID-19 emergencies May 11
This comes as lawmakers have already ended elements of the emergencies that kept millions of Americans insured during the pandemic.By Susan Walsh / AP
WHO says COVID remains an emergency but is in transition
The World Health Organization said there is still uncertainty in COVID-19's future, but the virus is at a "transition point."By Shutterstock
Long COVID patients use experimental shot for sense of smell issues
People are traveling from around the world to a Texas center that is testing a pain medication injection as a way to treat loss of smell from COVID.By Scripps News
Tom Brady announces he's retiring … again
"I'm retiring. For good," the 45-year-old quarterback and seven-time Super Bowl champion said in a video posted on social media.By John Raoux / AP
VP Kamala Harris to attend Tyre Nichols' funeral
Nichols will be laid to rest three weeks after he died following a beating by Memphis police.By Nichols family via AP
Winter storm causes 3rd day of dangerous, icy conditions
The storm began Monday as part of an expected "several rounds" of wintry precipitation through Wednesday in Texas, Oklahoma, Arkansas and Tennessee.By Elias Valverde II / The Dallas Morning News via AP